Vascular access site complications after PCI: current status and future directions

  • Michèle Hamon
  • Published 2006 in Nature Clinical Practice Cardiovascular Medicine


The use of combined antithrombotic therapies over the last two decades has substantially decreased the risk of a heart attack after percutaneous coronary intervention (PCI) but has also been associated with a significant increase in bleeding risk.1 Therapies or strategies that maintain the benefits seen with currently available antithrombotic therapies, but… (More)
DOI: 10.1038/ncpcardio0607